tiprankstipranks
Trending News
More News >
Biolife Sciences (BLFE)
OTHER OTC:BLFE
US Market

Biolife Sciences (BLFE) Income Statement

Compare
57 Followers

Biolife Sciences Income Statement

Last quarter (Q1 2022), Biolife Sciences's total revenue was $0.00, a decrease of ― from previous quarter. In Q1, Biolife Sciences's net income was $―. See Biolife Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 20Nov 19Nov 18Nov 17
Total Revenue
$ 411.69K$ 0.00$ 0.00$ 0.00
Gross Profit
$ -985.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 259.16K$ 0.00$ 42.28K$ 329.13K
Depreciation and Amortization
$ 206.30K$ 171.86K$ 0.00$ 0.00
EBITDA
$ -1.22M$ 171.86K$ -42.28K$ -329.00K
Operating Income
$ -1.24M$ 0.00$ -42.28K$ -329.00K
Other Income/Expenses
$ -24.04K$ -1.13K$ -10.44K$ -11.26K
Pretax Income
$ -1.27M$ -1.13K$ -52.72K$ -340.00K
Net Income
$ -1.27M$ -1.13K$ -52.72K$ -340.00K
Per Share Metrics
Basic EPS
$ -0.02$ >-0.01$ 0.00$ -0.08
Diluted EPS
$ -0.02$ >-0.01$ 0.00$ -0.08
Weighted Average Shares Outstanding
51.78M 19.45M 19.45M 4.45M
Weighted Average Shares Outstanding (Diluted)
51.78M 19.45M 19.45M 4.45M
Currency in USD

Biolife Sciences Earnings and Revenue History